PEMF Therapy in Shoulder Tendinopathy
NCT: NCT07550543 · RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies. The main questions it aims to answer are: * Does the addition of PEMF (SIS) therapy reduce pain intensity and improve pressure pain threshold compared to standard balneophysiotherapy? * Does PEMF (SIS) therapy improve shoulder function, muscle strength, psychological status, and quality of life? The study will compare a multimodal rehabilitation program supplemented with PEMF (SIS) therapy to standard balneophysiotherapy to determine whether the addition of PEMF (SIS) provides superior clinical outcomes. Participants will: * Undergo a multimodal rehabilitation program including balneophysiotherapy * Be assigned to receive either standard treatment or treatment supplemented with PEMF (SIS) therapy * Be evaluated at baseline (admission), immediately after treatment completion (discharge), and at 4 weeks after treatment using validated clinical instruments assessing pain, function, pressure pain threshold, muscle strength, psychological status, depressive symptoms, and quality of life.
Frequently Asked Questions
What is PEMF Therapy in Shoulder Tendinopathy?
PEMF Therapy in Shoulder Tendinopathy is a clinical trial registered under NCT07550543. Current status: RECRUITING.
What is the status of NCT07550543?
The current status of NCT07550543 (PEMF Therapy in Shoulder Tendinopathy) is: RECRUITING.
When did PEMF Therapy in Shoulder Tendinopathy start?
PEMF Therapy in Shoulder Tendinopathy started on 2026-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.